PTC Therapeutics, Inc. (PTCT)
74.68
+2.32
(+3.21%)
USD |
NASDAQ |
Feb 06, 16:00
74.51
-0.17
(-0.23%)
Pre-Market: 20:00
PTC Therapeutics Research and Development Expense (TTM) : 446.89M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 1.389B |
| Spyre Therapeutics, Inc. | 177.50M |
| Keros Therapeutics, Inc. | 157.36M |
| ACADIA Pharmaceuticals, Inc. | 344.78M |
| Alnylam Pharmaceuticals, Inc. | 1.248B |